| Financial Year |
March 31 2023 |
| Monetary Funds |
203,733,132.19 |
| Held-for-trading Financial Assets |
90,976,213.78 |
| Notes Receivable |
8,251,708.13 |
| Accounts Receivable |
374,135,473.32 |
| Advances to Suppliers |
10,511,664.30 |
| Other Receivables |
8,311,985.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
107,720,630.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
42,809,644.05 |
| Other Current Assets |
1,474,394.64 |
| Total Current Assets |
857,031,152.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,456,084.77 |
| Investment Properties |
-- |
| Fixed Assetes |
111,412,817.93 |
| Under-construction Projects |
4,819,093.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
8,659,414.68 |
| R&D expenses |
-- |
| Goodwill |
48,012,728.59 |
| Long-Term Deferred and Prepaid Expenses |
28,750,257.33 |
| Deferred Income Tax Assets |
37,283,150.00 |
| Other Non-Current Assets |
6,434,863.77 |
| Sub-Total of Non-Current Assets |
350,491,409.13 |
| Total Assets |
1,207,522,561.36 |
| Short-Term Loans |
32,800,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
85,589,224.30 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
21,556,463.75 |
| Taxes Payable |
13,448,740.64 |
| Interest Payable |
20,267.50 |
| Dividend Payable |
-- |
| Other payables |
6,182,624.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,981,393.99 |
| Other Current Liabilities |
3,994,265.80 |
| Sub-Total of Current Liabilities |
215,252,656.10 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
21,500,902.55 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
45,051,327.93 |
| Total Liabilities |
260,303,984.03 |
| Paid-In Capital(Or Share Stock) |
120,000,000.00 |
| Capital Surplus |
671,504,747.47 |
| Surplus Reserve |
9,614,003.37 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
88,015,339.15 |
| Minority Stockholder's Interest |
58,084,487.34 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
889,134,089.99 |
| Owner's Equity（Stockholder's Equity） |
947,218,577.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,207,522,561.36 |
